HD
32
-2
CL
56
-6
PG
45
-5
CMG
61
3
O
31
-8
CLX
51
-2
GOOG
55
-12
MLM
63
2
NRG
44
7
FITB
73
-3
PAYX
32
-4
VMC
53
3
JPM
67
-2
MRK
60
2
AON
67
2
PRU
60
-2
HBAN
79
-6
MET
63
-4
CCI
34
-2
MSFT
46
5
HD
32
-2
CL
56
-6
PG
45
-5
CMG
61
3
O
31
-8
CLX
51
-2
GOOG
55
-12
MLM
63
2
NRG
44
7
FITB
73
-3
PAYX
32
-4
VMC
53
3
JPM
67
-2
MRK
60
2
AON
67
2
PRU
60
-2
HBAN
79
-6
MET
63
-4
CCI
34
-2
MSFT
46
5
Financhill
Back

Goldman Sachs S&P 500 Premium Income ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy
52

GPIX
Goldman Sachs S&P 500 Premium Income ETF

Last Price:
$52.65
Seasonality Move:
-0.32%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Buy
52
Goldman Sachs S&P 500 Premium Income ETF (GPIX) is a Buy

Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?

  • The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $52.23. The Score for GPIX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • GPIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GPIX Stock Price Chart

What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?

  • The Goldman Sachs S&P 500 Premium Income ETF share price today is $52.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 48.17 Sell
Chaikin Money Flow: -309963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

GPIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.48 Sell
20-day SMA: 52.35 Sell
50-day SMA: 52.3 Sell
200-day SMA: 49.62 Buy
8-day EMA: 52.36 Sell
20-day EMA: 52.38 Sell
50-day EMA: 52.19 Buy
200-day EMA: 50.55 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Goldman Sachs S&P 500 Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):